Race and vitamin D binding protein gene polymorphisms modify the association of 25-hydroxyvitamin D and incident heart failure. The ARIC (Atherosclerosis Risk in Communities) Study

JACC: Heart Failure

Volumn 3, Issue 5, 2015, Pages 347-356

  Lutsey, Pamela L ^a   Michos, Erin D ^b   Misialek, Jeffrey R ^a   Pankow, James S ^a   Loehr, Laura ^c   Selvin, Elizabeth ^d   Reis, Jared P ^e   Gross, Myron ^f   Eckfeldt, John H ^f   Folsom, Aaron R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c IL   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

ARIC; Heart failure; Race; Vitamin D; Vitamin D binding protein

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D BINDING PROTEIN; 25-HYDROXYVITAMIN D; RNA; VITAMIN D;

ADULT; ARTICLE; BLACK PERSON; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC PREDISPOSITION; HEART FAILURE; HOSPITAL DISCHARGE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE; RISK FACTOR; VITAMIN BLOOD LEVEL; ANALOGS AND DERIVATIVES; ANCESTRY GROUP; ATHEROSCLEROSIS; BLOOD; CLINICAL TRIAL; EPIDEMIOLOGY; ETHNOLOGY; GENETIC POLYMORPHISM; GENETICS; INCIDENCE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; RISK ASSESSMENT; UNITED STATES;

ATHEROSCLEROSIS; CONTINENTAL POPULATION GROUPS; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS; RNA; UNITED STATES; VITAMIN D; VITAMIN D-BINDING PROTEIN;

EID: 84928791866     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2014.11.013     Document Type: Article

References (30)

1. Brøndum-Jacobsen P., Benn M., Jensen G.B., Nordestgaard B.G. 25-Hydroxyvitamin D levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies. Arterioscler Thromb Vasc Biol 2012, 32:2794-2802.
2. Meredith A.J., McManus B.M. Vitamin D in heart failure. JCard Fail 2013, 19:692-711.
3. Bolland M.J., Grey A., Gamble G.D., Reid I.R. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol 2014, 2:307-320.
4. Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. Dietary reference intakes for calcium and vitamin D 2010, Institute of Medicine, Washington, DC: National Academies Press (US). A.C. Ross, C.L. Taylor, A.L. Yaktine, H.B. Del Valle (Eds.).
5. Kunutsor S., Apekey T., Steur M. Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants. Eur J Epidemiol 2013, 28:205-221.
6. Song Y., Wang L., Pittas A.G., et al. Blood 25-Hydroxy Vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care 2013, 36:1422-1428.
7. Bikle D.D. Vitamin D regulation of immune function. Vitamin Horm 2011, 86:1-21.
8. Anderson J.L., May H.T., Horne B.D., et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 2010, 106:963-968.
9. Pilz S., Marz W., Wellnitz B., et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. JClin Endocrinol Metab 2008, 93:3927-3935.
10. Aloia J.F. African Americans, 25-hydroxyvitamin D, and osteoporosis: a paradox. Am J Clin Nutr 2008, 88:545S-550s.
11. Scragg R., Sowers M., Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004, 27:2813-2818.
12. Reis J.P., Michos E.D., von Muhlen D., Miller E.R. Differences in vitamin D status as a possiblecontributor to the racial disparity in peripheralarterial disease. Am J Clin Nutr 2008, 88:1469-1477.
13. Michos E.D., Reis J.P., Post W.S., et al. 25-Hydroxyvitamin D deficiency is associated with fatal stroke among whites but not blacks: The NHANES-III linked mortality files. Nutrition 2012, 28:367-371.
14. Robinson-Cohen C., Hoofnagle A.N., Ix J.H., et al. Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events. JAMA 2013, 310:179-188.
15. Powe C.E., Evans M.K., Wenger J., et al. Vitamin D-binding protein and vitamin D status of Black Americans and white Americans. NEngl J Med 2013, 369:1991-2000.
16. Harris S.S. Vitamin D and African Americans. JNutr 2006, 136:1126-1129.
17. Uitterlinden A.G., Fang Y., van Meurs J.B.J., Pols H.A.P., van Leeuwen J.P.T.M. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004, 338:143-156.
18. The Aric I. The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. Am J Epidemiol 1989, 129:687-702.
19. Inker L.A., Schmid C.H., Tighiouart H., et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. NEngl J Med 2012, 367:20-29.
20. Eriksson H., Caidaul K., Larsson B., et al. Cardiac and pulmonary causes of dyspnoea-validation of a scoring test for clinical-epidemiological use: The Study of Men Born in 1913. Eur Heart J 1987, 8:1007-1014.
21. Loehr L.R., Rosamond W.D., Chang P.P., Folsom A.R., Chambless L.E. Heart failure incidence and survival (from the Atherosclerosis Risk in Communities Study). Am J Cardiol 2008, 101:1016-1022.
22. Musunuru K., Lettre G., Young T., et al. Candidate Gene Association Resource (CARe): design, methods, and proof of concept. Circ Cardiovasc Genet 2010, 3:267-275.
23. Kim D.H., Sabour S., Sagar U.N., Adams S., Whellan D.J. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol 2008, 102:1540-1544.
24. Altay H., Colkesen Y. Parathyroid hormone and heart failure: novel biomarker strategy. Endocr Metab Immune Disord Drug Targets 2013, 13:100-104.
25. Newman K.P., Bhattacharya S.K., Munir A., Davis R.C., Soberman J.E., Ramanathan K.B. Macro-and micronutrients in patients with congestive heart failure, particularly African-Americans. Vasc Health Risk Manag 2007, 3:743-747.
26. Boxer R.S., Kenny A.M., Schmotzer B.J., Vest M., Fiutem J.J., Piña I.L. Arandomized controlled trial ofhigh-dose vitamin D3 in patients with heart failure. JAm Coll Cardiol HF 2013, 1:84-90.
27. Wang X., Cheng S., Brophy V.H., et al. Ameta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients. Stroke 2009, 40:683-695.
28. Clarke R., Shipley M., Lewington S., et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol 1999, 150:341-353.
29. Grant W.B. Effect of follow-up time on therelation between prediagnostic serum 25-hydroxyvitamin D and all-cause mortality rate. Dermatoendocrinol 2012, 4:198-202.
30. Rosamond W.D., Chang P.P., Baggett C., et al. Classification of heart failure in the Atherosclerosis Risk in Communities (ARIC) study: a comparisonofdiagnostic criteria. Circ Heart Fail 2012, 5:152-159.